These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16626441)

  • 21. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A; Isola V; Vadalà M; Calori G
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Axer-Siegel R; Ehrlich R; Rosenblatt I; Kramer M; Priel E; Yassur Y; Weinberger D
    Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis.
    Shanmugam MP; Agarwal M
    Indian J Ophthalmol; 2005 Mar; 53(1):61-3. PubMed ID: 15829751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy in patients with idiopathic choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):422-4. PubMed ID: 15295678
    [No Abstract]   [Full Text] [Related]  

  • 25. Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Acta Ophthalmol Scand; 2007 Feb; 85(1):50-4. PubMed ID: 17244210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 28. Photodynamic therapy for chronic serous detachment of the retinal pigment epithelium in a young patient.
    Olivier S; Harissi-Dagher M; Sébag M
    Can J Ophthalmol; 2005 Apr; 40(2):214-6. PubMed ID: 16049540
    [No Abstract]   [Full Text] [Related]  

  • 29. Macular hole following photodynamic therapy.
    Mansour AM; Husseini ZM; Schakal AR
    Ophthalmic Surg Lasers; 2002; 33(6):511-3. PubMed ID: 12449231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of RPE damage after photodynamic therapy in patients with idiopathic choroidal neovascularization].
    Li XX; Zhao MW; Qu JF
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):206-11. PubMed ID: 17605901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
    Lai TY; Chan WM; Lam DS
    Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium.
    Cilliers H; Harper CA
    Clin Exp Ophthalmol; 2006 Mar; 34(2):186-8. PubMed ID: 16626442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute posterior multifocal placoid pigment epitheliopathy and choroidal neovascularization.
    Bowie EM; Sletten KR; Kayser DL; Folk JC
    Retina; 2005; 25(3):362-4. PubMed ID: 15805916
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of subfoveal choroidal neovascularization secondary to choroidal nevus using photodynamic therapy.
    Levy J; Shneck M; Klemperer I; Lifshitz T
    Ophthalmic Surg Lasers Imaging; 2005; 36(4):343-5. PubMed ID: 16156155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy in symptomatic parafoveal telangiectasia secondary to Osler-Rendu-Weber disease.
    Mennel S; Hoerle S; Meyer CH
    Acta Ophthalmol Scand; 2006 Apr; 84(2):273-5. PubMed ID: 16637855
    [No Abstract]   [Full Text] [Related]  

  • 37. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy for extrafoveal choroidal neovascularization associated with choroidal nevus.
    Moon SJ; Wirostko WJ
    Retina; 2006 Apr; 26(4):477-9. PubMed ID: 16603973
    [No Abstract]   [Full Text] [Related]  

  • 39. Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.
    Sawa M; Ohji M; Gomi F; Kusaka S; Tano Y; Bressler NM
    Arch Ophthalmol; 2002 Nov; 120(11):1588-90. PubMed ID: 12427082
    [No Abstract]   [Full Text] [Related]  

  • 40. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.